Rajat N Agrawal, MD, MS’ Post

View profile for Rajat N Agrawal, MD, MS, graphic

Ophthalmologist | Retina Specialist | Clinical Development | Regulatory Strategy | Medical Affairs | Business Development | Due Diligence | Commercial & Corporate Strategy | Board Member | Consulting | Investment

Join the All Star Panelists, Arshad M. Khanani; Firas M. Rahhal, MD; Ram Palanki; George Magrath; and Maryam Mokhtarzadeh, M.D. at the Association for Research in Vision and Ophthalmology (ARVO) Special Interest Group (SIG) discussion on "Oral Medications for Management of Retinal Diseases". The session is being moderated by Charles DeBoer and myself. With many attempts to address to treatment burden for both patients and clinicians, oral medications appear to have become a significant focus as a likely treatment option for retinal diseases. This SIG will discuss the various programs and the background information about what it takes to plan and implement an oral med clinical study, various endpoints, what the regulators are likely to look at for approval, and what will it take to commercialize and market these products if and when they get approved. We also encourage the audience to partake in the discussion - we welcome questions and will raise these questions in front of the panel during the SIG. Feel free to ask any questions you may have. Join us for this interesting conversation - the SIG is on July 11, 2024, 3-430pm PST. If you haven't registered, please do so quickly. The panel and the moderators are looking forward to this event!

  • No alternative text description for this image
Vikas Khetan

Professor at Flaum Eye Institute

3mo

Great opportunity! Link to register?

Like
Reply
Maryam Mokhtarzadeh, M.D.

Innovator. Champion. Strategist. l Clinical │ Policy │ Regulatory │ Industry Expert │ across Drugs, Devices, & Biologics

3mo

Raj, thanks for the opportunity. You and Charles led an insightful and lively discussion! I enjoyed contributing

See more comments

To view or add a comment, sign in

Explore topics